-
-
-
-
-
-
-
Eli Lilly shares pop as weight-loss drug demand fuels guidance hike
-
-
-
-
-
-
-
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
-
-
-
-
-
-
-
Novo Nordisk reports Q1 earnings on Wednesday: Analysts flag key focus topics
-
-
-
-
-
-
-
Eli Lilly Q1 earnings preview: analysts eye outlook for obesity drugs
-
-
-
-
-
-
-
Lilly confirms date and conference call for first-quarter 2026 financial results announcement
-
-
-
-
-
-
-
This pharma stock is 'poised to outperform in 2026,' Wolfe says
-
-
-
-
-
-
-
Bernstein Weighs In on Eli Lilly (LLY) Stock Following Novo Pre-Release
-
1,225,985 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

